Cybin-backed HELP trial eyes HLP003 Phase III data in Q4 2026
A late-stage mental health pipeline includes HLP003 in Phase III for adjunctive MDD, with top-line data expected in Q4 2026 and an NDA filing targeted for 2028.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.